caregiver and patient

Liver Disease Treatment

Liver disease can threaten your life. The liver cleans your blood and fights infections. It helps you digest food and store energy. An unhealthy liver can't do any of these things. Getting liver disease treatment as soon as possible keeps you alive.

Liver Disease Treatment Experts

At UVA, you'll find a world-class team of hepatology specialists. We can stop your liver disease from getting worse. 

Conditions We Treat

  • Hepatoma
  • Metastatic liver disease
  • NASH (nonalcoholic steatohepatitis) fatty liver disease
  • Alpha-1 antitrypsin deficiency
  • Autoimmune hepatitis
  • Hemochromatosis
  • Primary biliary cirrhosis
  • Primary sclerosing cholangitis
  • Wilson’s disease
Hepatology Specialties

Fatty Liver Disease

Get treated by leaders in hepatology. We specialize in fatty liver disease, including nonalcoholic steatohepatitis (NASH).

Hepatitis

You can benefit from customized therapies. We partner with specialists in infectious disease to give you tailored treatment. Patients with hepatitis get better faster due to our advanced approach to treatment.  

Care Without Surgery

Liver scarring can cause bleeding in your GI tract. When possible, we avoid surgery. We stop the bleeding with a glue injection.

Liver Disease Treatment for Chronic Conditions

We researched a better way to control chronic, end-stage liver disease. Medicine that suppresses hepatitis can improve liver function.

Liver Research
researcher at work

We're developing new drugs for hepatitis. Our research also aims to find new tests and therapies for liver disease.

Read About Our Liver Research
Liver Cancer
surgeons at work

We offer all forms of therapy for liver cancer. This includes liver tumor removal.

View Liver Cancer Therapies
Liver Transplant
liver transplant patient

Become a living liver donor. And access the latest therapies to prevent infection after liver transplant.

Learn About Liver Transplant

Liver Care Clinical Trials

Research study for subjects with Clostridium difficile infection (referred to as CDI)

The Division of Gastroenterology and Hepatology seeks adults ages 18-75 with CDI for a research study. The purpose of the study is to evaluate potential side effects and effectiveness of taking an investigational medicine (CP101) in a single dose…

Research study for Crohn’s patients with perianal fistulas

The Division of Gastroenterology and Hepatology seeks adults, 18-75, with Crohn’s disease and perianal fistulas for a research study. The purpose of the study is to find out how well the study drug, Cx601, works compared to a placebo, including…

Study for adults with PSC cirrhosis

The Division of Gastroenterology and Hepatology seeks adults 18-75 with primary sclerosing cholangitis (PSC) and cirrhosis for a research study. The purpose of the study is to determine the safest dose of cilofexor, an experimental medication,…

Study for adults with fatty liver disease who are having a liver biopsy

The Division of Gastroenterology and Hepatology seeks adults, 18-75, with fatty liver disease for a research study. The purpose of the study is to compare LiverMultiScan, a type of MRI, to liver biopsy.

You may be eligible for this study…

Research study for those with moderate to severe Crohn’s disease

The Division of Gastroenterology and Hepatology seeks adults ages 18-75 with Crohn’s disease for a research study. The purpose of the study is to evaluate the safety and effectiveness of an investigational drug called Filgotinib in treating…